Multi‐Omics Profiling Uncovers Predictive Factors for Tumor‐Infiltrating Lymphocyte Therapy in Ovarian Cancer
Our findings provide insights into factors affecting TIL therapy efficacy in OC and suggest potential strategies for optimizing patient selection and TIL manufacturing protocols.
Institutions
- National Institutes of Health (US)
- Harry Perkins Institute of Medical Research (AU)
- Hainan General Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Shenzhen Second People's Hospital (CN)
- Hainan Medical University (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Journal of Clinical Laboratory Analysis
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1002/jcla.70196
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00